Main Menu

NASDAQ (usa) arrow 6715.56 -12.11 -0.18%
FTSE 100 (london) arrow 7487.96 -5.12 -0.07%
DAX (german) arrow 13465.51 235.94 1.78%
NIKKEI 225 (japan) arrow 22420.08 408.47 1.86%
Hang - Seng (hong kong) arrow 28594.06 348.52 1.23%
NIFTY - 50 (india)
Straits Times (singapore) arrow 3391.61 17.53 0.52%
KOSPI (korea) arrow 2556.47 33.04 1.31%
All Ordinaries (australia) arrow 6005.30 28.90 0.48%
BOVESPA (brazil) arrow 74092.76 -215.73 -0.29%

Actinogen Medical Limited (AU: ACW)

 
ACW Technical Analysis
2
As on 22nd Nov 2024 ACW STOCK Price closed @ 0.03 and we RECOMMEND Buy for LONG-TERM with Stoploss of 0.03 & Strong Sell for SHORT-TERM with Stoploss of 0.04 we also expect STOCK to react on Following IMPORTANT LEVELS.
 
 

ACWSTOCK Price

Open 0.02 Change Price %
High 0.03 1 Day 0.01 50.00
Low 0.02 1 Week 0.01 50.00
Close 0.03 1 Month 0.00 0.00
Volume 6340377 1 Year -0.02 -40.00
52 Week High 0.09 | 52 Week Low 0.02
 
AU Australia Most Active Stocks
OVT 0.02 %
SYA 0.03 0.00%
PLS 2.61 -6.79%
TMK 0.00 %
ROG 0.01 0.00%
FAU 0.00 %
FFG 0.02 0.00%
RSG 0.40 0.00%
PEN 0.06 0.00%
IMU 0.04 0.00%
 
AU Australia Top Gainers Stocks
APV 0.02 100.00%
RFT 0.02 100.00%
PCL 0.02 100.00%
SCI 0.03 50.00%
SCI 0.03 50.00%
SCI 0.03 50.00%
SCI 0.03 50.00%
SCI 0.03 50.00%
SCI 0.03 50.00%
ACW 0.03 50.00%
 
AU Australia Top Losers Stocks
FIN 0.00 -100.00%
LML 0.00 -100.00%
LML 0.00 -100.00%
BMO 0.00 -100.00%
BMO 0.00 -100.00%
BMO 0.00 -100.00%
GRL 0.01 -50.00%
GRL 0.01 -50.00%
RCP 0.02 -33.33%
RCP 0.02 -33.33%
 
 
ACW
Daily Charts		 ACW
Intraday Charts		 Whats New @
Bazaartrend		 ACW
Free Analysis
 
ACW Important Levels Intraday
RESISTANCE0.05
RESISTANCE0.04
RESISTANCE0.04
RESISTANCE0.04
SUPPORT0.02
SUPPORT0.02
SUPPORT0.02
SUPPORT0.01
 
ACW Forecast November 2024
Share
4th UP Forecast0.07
3rd UP Forecast0.06
2nd UP Forecast0.05
1st UP Forecast0.04
1st DOWN Forecast0.02
2nd DOWN Forecast0.01
3rd DOWN Forecast0
4th DOWN Forecast-0.01
 
ACW Weekly Forecast
4th UP Forecast0.05
3rd UP Forecast0.04
2nd UP Forecast0.04
1st UP Forecast0.04
1st DOWN Forecast0.02
2nd DOWN Forecast0.02
3rd DOWN Forecast0.02
4th DOWN Forecast0.01
 
ACW Forecast2024
4th UP Forecast0.18
3rd UP Forecast0.13
2nd UP Forecast0.1
1st UP Forecast0.07
1st DOWN Forecast-0.01
2nd DOWN Forecast-0.04
3rd DOWN Forecast-0.07
4th DOWN Forecast-0.12
 
 
ACW Other Details
Segment EQ
Market Capital 225782112.00
Sector Healthcare
Industry Biotechnology
Offical website >
 
ACW Address
ACW
 
ACW Latest News
 
Your Comments and Response on Actinogen Medical Limited
 
ACW Business Profile
Actinogen Medical Limited, a biotechnology company, develops therapies for cognitive impairment associated with chronic neurological diseases in Australia. The company is developing Xanamem, a therapy for Alzheimer's disease, and cognitive impairment associated with schizophrenia, diabetes, and other disorders; and XanADu, which has completed Phase II clinical trials is a double-blind, randomized, and placebo-controlled study to assess the safety, tolerability, and efficacy of Xanamem in subjects with mild Alzheimer's disease. It is also developing XanaHES, a single blinded, central reader blinded, placebo-controlled, and dose escalation study of Xanamem to assess safety and tolerability in healthy elderly subjects. The company was formerly known as Actinogen Limited and changed its name to Actinogen Medical Limited in November 2015. Actinogen Medical Limited was incorporated in 1999 and is headquartered in Sydney, Australia. Address: 109 Pitt Street, Sydney, NSW, Australia, 2000
 
© 2005-2023 BazaarTrend.com All rights reserved.

Data and information is provided for informational purposes only, and is not intended for trading purposes.
Neither BazaarTrend.com website nor any of its promoters shall be liable for any errors
or delays in the content, or for any actions taken in reliance thereon. Your use of this website constitutes
acceptance of our Terms Of Service